date, we do not know the etiological agents of Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS) that trigger the production of specific antibodies (autoimmune reaction) in the bloodstream, against aquaporin…
impaired mitochondrial function has been implicated in the pathogenicity of multiple sclerosis (MS), a chronic inflammatory, demyelinating, and neurodegenerative disease of the CNS. We investigated whether variants in…
Multiple Sclerosis (MS) is a neurodegenerative disease characterized by repeated inflammatory events, demyelination and axonal damage, along with loss of function. MS exhibited different forms: relapsing remitting…
Multiple sclerosis is a chronic, complex disease with a variety of clinical symptoms and affects mainly young and middle-aged people. Research and therapies are focused on the early phase ... showed. First of all this…
Multiple sclerosis (MS) is a common, autoimmune inflammatory disorder of the central nervous system (CNS) characterized by demyelination and succeeding axonal degeneration. The remission and recurrent relapsing disease…
Recent studies propose that multiple sclerosis (MS) is not only a demyelinating disorder but a primary degenerative disease accompanied with whole brain atrophy. Brain atrophy, indeed, might happen without…
Dysregulation or mutation of miRNAs has been linked to autoimmune diseases such as multiple sclerosis and Experimental Autoimmune Encephalomyelitis (EAE). However, the meaning of the alteration in miRNA expression level…
Multiple Sclerosis (MS) is characterized by inflammatory and neurodegenerative changes in the brain and spinal cord. Measurement of disease activity can be considered at two levels: Clinical parameters which include…
Background:With the ever-growing competitive landscape in conducting Multiple Sclerosis (MS) clinical trials and the unmet needs for more robust effects on long term disability and disease progression, novel…
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder with neurodegenerative effects. It is usually seen among young adults and women. The aim of the present investigation was the study ... required…
multiple sclerosis (MS). The aim of this study was to analyze the effects of methylprednisolone, interferon-1b (INF) and glatiramer acetate (GA) on leptin, resistin, and adiponectin concentrations in relapsing
explain some of the uncommon differentials which have similar manifestations like NMOSD. Example Multiple sclerosis (MS), Acute disseminated encephalomalitis (ADEM), Subacute combined neuro degeneration…
Dysregulation or mutation of miRNAs has been linked to autoimmune diseases, such as multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). However, the meaning of the alteration in miRNA expression…
inflammation and demyelination typically targeting optic nerves & spinal cord. Patients often experience a relapsing course of cumulative neurological debility. Latest epidemiologic data suggest hundreds of thousands of…
Dysregulation or mutation of miRNAs has been linked to autoimmune diseases, such as Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE). However, the meaning of the alteration in miRNA expression…
Multiple sclerosis (MS) is a chronic neurological disease, and the cause of MS remains unknown. There is no cure for MS, but several disease-modifying treatments (DMT) are available ... prevent disease progression for…
Perturbations in immune processes play an important role in multiple sclerosis (MS), an autoimmune disorder where specific innate immune pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs) have…
Multiple sclerosis (MS) is a multifaceted disease of the central nervous system. We discovered that progressive MS patients have lower levels of apolipoprotein A-I (ApoA-I) in serum ... plasma compared to healthy…
Multiple sclerosis (MS) is a multifaceted disease of the central nervous system. We discovered that progressive MS patients have lower levels of apolipoprotein A-I (ApoA-I) in serum ... plasma compared to healthy…
which frequently culminate in severe neurological abnormalities. Although there has been substantial progress in relapse treatment and prevention in recent years, the residual impairment per attack remains high. Despite…
this study. Each individual completed the Multiple Sclerosis Self-Efficacy scale (MSSE), the Multiple Sclerosis Impact Scale (MSIS-29), and the Good in Leisure-Time Exercise Questionnaire (GLTEQ). Pearson product…
Detection of multiple sclerosis (MS) is a challenging process, which usually requires repeated imaging over time. Th e absence of unequivocal detection tests delays initiation of treatment thus increasing potential…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.